Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sheppard Pratt Health System
With
Stanley Medical Research Institute
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18-65
Capacity for written informed consent
Currently admitted to a Sheppard Pratt inpatient or day hospital for symptoms of mania
Primary Axis I diagnosis (DSM-IV) at time of admission of Bipolar I Disorder (single manic episode, most recent episode manic, or most recent episode mixed) OR Schizoaffective Disorder, Bipolar type (manic or mixed state)
Proficient in the English language
Available to come to Sheppard Pratt Towson for follow-up visits
Participated previously in one of our screening studies
You may not be if
Diagnosis of mental retardation
Symptoms of mania secondary to a general medical condition
Any clinically significant or unstable medical disorder as determined by the investigators including congestive heart failure, abnormal liver function or disease, renal failure, acute pancreatitis, any diagnosis of cancer undergoing active treatment, HIV infection or other immunodeficiency condition
History of IV drug use
Primary diagnosis of substance abuse or dependence according to DSM-IV criteria within the last 3 months, or has a positive drug toxicity screen
Participated in any investigational drug trial in the past 30 days
Pregnant or planning to become pregnant during the study period
Receipt of antibiotic medication within the previous 24 hours (as anaerobic organisms residing in the gastrointestinal tract may be minimally affected by antibiotics)
Documented celiac disease (as such persons should be on a gluten-free diet as this is the standard care). Of note, we are not limiting the study to individuals with elevated levels of gliadin or casein antibodies as we intend to look at these levels as a predictor of response.
Clareo Health | Probiotics to Prevent Relapse After Hospitalization for Mania
